Skip to main content
Fig. 2 | Annals of Intensive Care

Fig. 2

From: Serial daily lactate levels association with 30-day outcome in cardiogenic shock patients treated with VA-ECMO: a post-hoc analysis of the HYPO-ECMO study

Fig. 2

A Kaplan–Meier analysis for 30-day all-cause mortality according to hyperlactatemia status (> 2.2 mmol/L) versus normolactatemia (≤ 2.2 mmol/L) at baseline. B Hazard ratio of 30-day mortality according to lactate value measured at any time over the first seven days (time-dependent analysis). C Cox model analysis according to lactate at baseline (time-fixed variable) and to late lactate re-increase over the first 7 days (time dependent variable). D: 30-day mortality according to three trajectories of lactate evolution over the first seven days according to latent class analysis method. HR, hazard ratio. Adjusted p values were calculated from imputed data in all panels

Back to article page